drugset / Trial / NCT01623908
Bone Loss Treatment From Adjuvant Zoledronate Efficacy
NaSingle-groupOpen-labelTreatment
Summary
The main purpose of this study is to observe and assess the impact of adjuvant zoledronate on bone density in breast cancer patients. The second purposes: * The efficacy of adjuvant zoledronate * The safety of adjuvant zoledronate * The bone loss of breast cancer patients in Guangdong * The correlation between bone loss of breast cancer patients and treatment of disease in Guangdong
Timeline
- Start
- 2011-07
- Primary completion
- 2013-06
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zoledronate | Other / unclassified | 4 mg | Intravenous |